the vaccine – Page 3 – Communicable Diseases Research

Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID-19 vaccine

Article

Published on 2022-11-012022-11-15
Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] analyzed antibody Antibody titer B cell booster booster dose caused Cell Cluster Concentration conducted COVID-19 COVID-19 vaccine CyTOF Cytometry declined decrease distribution Efficacy ENhance healthy highlight humoral Immune cell immune response Immunity immunization immunoassay immunological profile inactivated individual injection Injections lack maintain marker multicenter neutralizing antibody not significantly different participant prevalence of COVID-19 proportion protective effect recall receiving recruited reduced SARS-CoV-2 second dose serum antibody shown significantly significantly increased Still subject surface marker sVNT the antibody response the vaccine vaccination Vaccine vaccine doses vaccine injection Viral variants virus neutralization test
[DOI] 10.1002/jmv.27983 PMC 바로가기

Attitude toward COVID-19 vaccines and its association with depressive symptoms in 386,924 Chinese primary school students during COVID-19 epidemic normalization

Research article

Published on 2022-11-012022-10-05
Journal: Journal of psychosomatic research [Category] 변종,

Public acceptance of COVID-19 vaccination among residents of Saudi Arabia: a cross-sectional online study

Article

Published on 2022-10-312022-11-15
Journal: BMJ Open [Category] 치료제,

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

Article

Published on 2022-10-272022-11-15
Journal: PLoS Medicine [Category] COVID19(2023년), SARS, 진단,

[키워드] 95% CI Ad26.COV2.S Ad26.COV2.S vaccine age Analysis anti-SARS-CoV-2 Anti-spike antibody Antibody Response Antiretroviral therapy approved assays BNT162b2 CD4+ T-cell CD8+ T-cell ChAdOx1-S comparable Concentration conducted Control controls COVID-19 defined ELISPOT Endpoint Environment Final generally mild geometric HIV HIV-negative IFN-γ immunogenic immunogenicity Increased IQR less maintain male marker median age mRNA vaccination mRNA vaccine mRNA-1273 mRNA-based vaccines Netherland Netherlands of BNT162b2 PLWH predicted primary endpoint prospective cohort study Public reactogenicity receiving recipients reduced Registered remained required response SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 spike peptide SARS-CoV-2 vaccination SARS-CoV-2 vaccine secondary Serious Adverse Events serological response Sex suppressed T-cell Response the median the vaccine Trial vaccination Vaccine vaccine group Viral load with HIV
[DOI] 10.1371/journal.pmed.1003979 PMC 바로가기

Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant

Article

Published on 2022-10-262022-11-15
Journal: Vaccine [Category] COVID19(2023년), SARS, 진단,

[키워드] adverse event Affect analyzed Anti-spike RBD IgG antibody antibody response against Blood Group Breakthrough infection cellular response ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine chronic Chronic kidney disease CKD comparable Control controls Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 vaccination exhibited first dose group healthy controls Hemodialysis humoral Illness severity immune response immunological responses Inactivated vaccine incidence of COVID-19 individual injection kidney kidney transplant less lowest neutralizing antibody occurred outcome Patient patient group Peritoneal dialysis Protective RBD robust SARS-CoV-2 vaccine secondary single dose suggested T cell response the S protein the vaccine total population understanding vaccination Vaccine virus neutralization test
[DOI] 10.1016/j.vaccine.2022.09.067 PMC 바로가기

Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals

Article

Published on 2022-10-262022-11-15
Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 진단,

[키워드] ACE-2 ACE2 ACE2 binding analyzed Angiotensin converting enzyme-2 Anti-RBD IgG Anti-spike anti-spike antibody anti-Spike IgG antibody binding blood collection BNT162b2 calculated collected Concentration correlated correlation correlation coefficient correlation coefficients COVID-19 COVID-19 antibody demonstrated dosing interval examined Fisher group groups IgG individual inhibition interval intervals labor-intensive measure mRNA mRNA-1273 vaccines Neutralizing antibodies neutralizing antibody Neutralizing antibody titer neutralizing antibody titers NTD Participants performed RBD Sample SARS-CoV-2 Secondary analyses Spearman correlation coefficient subgroup tested the median the vaccine titer vaccinated individual vaccination Vaccine vaccinee vaccinees Validity viral neutralization wild-type with COVID-19 women
[DOI] 10.1128/spectrum.01315-22 PMC 바로가기

Neutralizing SARS-CoV-2 Spike Antibodies against Omicron in Paired Samples after Two or Three Doses of mRNA Vaccine

Article

Published on 2022-10-262022-11-15
Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, 치료제,

‘Mix and Match’ vaccination: Is dengue next?

Article

Published on 2022-10-262022-11-15
Journal: Vaccine [Category] COVID19(2023년), SARS, 진단,

Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis

Article

Published on 2022-10-252022-11-15
Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종, 진단,

Revealing Public Opinion towards the COVID-19 Vaccine with Weibo Data in China: BertFDA-Based Model

Article

Published on 2022-10-142022-11-16
Journal: International Journal of Environmental Research an [Category] 변종,